Clinical Trial Update: Effectiveness of GlaxoSmithKline Biologicals S.A's Meningococcal Group B and Combined ABCWY Vaccines in Healthy Adolescents and Young Adults [Phase 3]

View source ↗

Summary

Phase 3 trial update assessing the effectiveness of GlaxoSmithKline's meningococcal Group B and ABCWY vaccines in healthy adolescents and young adults has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Disease
• Meningococcal Infections

Drugs mentioned

• ABCWY vaccine
• Meningococcal group B vaccine (Neisseria meningitidis serogroup B vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Meningococcal | Phase 3 | Status: COMPLETED | Results posted: 2024-03-05